Medical Digest & Congress Report
Episodes
Targeting CD19+ B-Cells in IgG4-Related Disease: Clinical Evidence and Implications for Long-Term Management - Report from EULAR 2026
15 Jun 2026
Contributed by Lukas
Dr. Emanuel Della Torre discusses the clinical evidence behind targeting CD19+ B-cells in IgG4-related disease in a post-congress interview following ...
State-of-the-Art Treatment in Psoriatic Arthritis - Report from EULAR 2026
15 Jun 2026
Contributed by Lukas
Professor Laura C. Coates highlights the rapidly evolving landscape of state-of-the-art treatments for psoriatic arthritis (PsA) in a post-congress in...
The RA Paradigm Shift: New Insights into Pathogenesis and a Pipeline of Promise - Report from EULAR 2026
15 Jun 2026
Contributed by Lukas
Professor Elena Nikiphorou discusses the ongoing paradigm shift in rheumatoid arthritis (RA), presented at the EULAR 2026 Congress. This recap focuses...
Systemic Sclerosis: Deciphering Pathogenesis, Unveiling Comorbidities, and Paving the Way for Targeted Treatment - Report from EULAR 2026
15 Jun 2026
Contributed by Lukas
Professor Oliver Distler dives into the complex landscape of systemic sclerosis (SSc), presented at the EULAR 2026 Congress. This recap focuses on rec...
EULAR / ACR Classification Criteria for Anti-Synthetase Syndrome - Report from EULAR 2026
15 Jun 2026
Contributed by Lukas
Professor Lorenzo Cavagna discusses the developed EULAR / ACR classification criteria for anti-synthetase syndrome, presented at the EULAR 2026 Congre...
Workflow in Focus: Advancing Global Health in Rheumatology - Report from EULAR 2026
15 Jun 2026
Contributed by Lukas
Professor Annelies Boonen explores systemic workflows and their critical role in advancing global healthcare within rheumatology, presented at the EUL...
Diagnosing Osteoporosis in Inflammatory Rheumatic Conditions - Report from EULAR 2026
15 Jun 2026
Contributed by Lukas
Professor Radmila Matijevic addresses the complexities of diagnosing osteoporosis within the context of inflammatory rheumatic conditions, presented a...
Biosimilars in Focus: Advancing Global Health in Rheumatology - Report from EULAR 2026
15 Jun 2026
Contributed by Lukas
Professor Tore K. Kvien explores the evolving landscape of biosimilars and their vital role in advancing global healthcare within rheumatology, presen...
Treating Hypertension in the Elderly: Insights from the ESH Congress
15 Jun 2026
Contributed by Lukas
Dr. Paul Whelton shares critical insights from the ESH Congress on the management of hypertension in the elderly. While high blood pressure is highly ...
Screen, Monitor and Manage CTD-ILD: Practical Application of ERS/EULAR Guidelines and Expert Insights - Report from EULAR 2026
15 Jun 2026
Contributed by Lukas
Dr. Francesco Del Galdo discusses the screening, monitoring, and management of connective tissue disease-associated interstitial lung disease (CTD-ILD...
Treatment of Rheumatoid Arthritis Associated Interstitial Lung Disease - Report from EULAR 2026
15 Jun 2026
Contributed by Lukas
Dr. Philippe Dieudé discusses current strategies for treating interstitial lung disease associated with rheumatoid arthritis (RA-ILD), presented at t...
Promote Happiness: Rethinking Care for Brighter Outcomes in Older Adults with RMDs - Report from EULAR 2026
15 Jun 2026
Contributed by Lukas
Dr. José Antonio P. Da Silva discusses the importance of promoting happiness and well-being in older adults living with rheumatic and musculoskeletal...
Improving Care in Spondyloarthritis: A Multidisciplinary Approach to the Disease and Its Extra-Musculoskeletal Manifestations - Report from EULAR 2026
15 Jun 2026
Contributed by Lukas
Dr. Filip Van den Bosch discusses strategies for improving care in spondyloarthritis, presented at the EULAR 2026 Congress. This recap focuses on the ...
HPR Sessions at EULAR 2026
15 Jun 2026
Contributed by Lukas
Dr. Mwidimi Ndosi provides an overview of the key Health Professionals in Rheumatology (HPR) sessions at the EULAR 2026 Congress. This recap highlight...
The Patient is in the Middle - Report from EULAR 2026
15 Jun 2026
Contributed by Lukas
Dr. Mwidimi Ndosi explains the role of patient-centered care in rheumatology, presented at the EULAR 2026 Congress. This recap covers the practical us...
Secukinumab in Polymyalgia Rheumatica: Results of the Phase 3 REPLENISH Trial - Report from EULAR 2026
15 Jun 2026
Contributed by Lukas
Dr. Christian Dejaco presents highly anticipated data from the Phase 3 REPLENISH trial, evaluating the efficacy and safety of secukinumab in patients ...
No Pain is THE Gain in Rheumatoid Diseases - Report from EULAR 2026
15 Jun 2026
Contributed by Lukas
Dr. Lars Arendt-Nielsen delivers a compelling expert perspective on revolutionizing treatment priorities in rheumatic and musculoskeletal diseases, fe...
Unveiling Novel Antibodies and Their Practical Implication in RMDs - Report from EULAR 2026
15 Jun 2026
Contributed by Lukas
Dr. Diane van der Woude provides a fascinating expert overview of the discovery of novel autoantibodies and their clinical translation in rheumatic an...
HPR: Patient Education, Support and Improving Access to Rheumatology Care - Report from EULAR 2026
15 Jun 2026
Contributed by Lukas
Rikke Helene Moe, EULAR Vice-President HPR, delivers an inspiring expert overview of the vital role Health Professionals in Rheumatology (HPR) play in...
Pain Management in Rheumatological Diseases - Report from EULAR 2026
15 Jun 2026
Contributed by Lukas
Dr. Jasminka Milas-Ahic provides a comprehensive expert overview of the contemporary challenges and advancements in pain management across rheumatolog...
Managing Comorbidities in Systemic Sclerosis to Achieve Better Outcome - Report from EULAR 2026
15 Jun 2026
Contributed by Lukas
Dr. Claudia Iannone delivers a vital expert perspective on the strategic management of comorbidities in patients with Systemic Sclerosis, featured at ...
Managing Comorbidities in Rheumatoid Arthritis for Better Outcome - Report from EULAR 2026
15 Jun 2026
Contributed by Lukas
Dr. Claudia Iannone delivers a vital expert perspective on the strategic management of comorbidities in patients with Rheumatoid Arthritis, featured a...
Novel Development in Treatment of Lupus - Report from EULAR 2026
15 Jun 2026
Contributed by Lukas
Dr. Anca Dinu Askanase provides an essential expert overview of the latest breakthrough advancements and novel therapeutic developments in the treatme...
Impact of Sonelokimab on Clinical and Imaging Outcomes in Axial Spondyloarthritis: Results of a Phase 2 Study - Report from EULAR 2026
15 Jun 2026
Contributed by Lukas
Professor Xenofon Baraliakos, President of EULAR, presents pivotal data from a Phase 2 study evaluating the impact of sonelokimab, an IL-17A/F-inhibit...
From Diagnosis to Family Building: Navigating Fertility in RMDs - Report from EULAR 2026
15 Jun 2026
Contributed by Lukas
Dr. Laura Andreoli and Dr. Karen Schreiber share essential insights from EULAR 2026 on managing fertility and family planning in patients with rheumat...
Novel Treatment Horizons in Lupus: Key Updates from EULAR 2026
15 Jun 2026
Contributed by Lukas
Dr. Victoria Werth provides a concise update on the rapidly evolving therapeutic landscape for lupus, highlighting breakthrough data from EULAR 2026. ...
Highlights of EULAR 2026
15 Jun 2026
Contributed by Lukas
Professor Xenofon Baraliakos, President of EULAR, delivers an authoritative executive summary of the definitive highlights from the EULAR 2026 Congres...
Chest HRCT in Detecting, Staging and Follow Up of SARD-ILD - Report from EULAR 2026
15 Jun 2026
Contributed by Lukas
Dr. Muriel Elhai provides an essential expert overview of the critical role of chest high-resolution computed tomography (HRCT) in systemic autoimmune...
Clinical Manifestations and Disease Course in Systemic Sclerosis - Report from EULAR 2026
15 Jun 2026
Contributed by Lukas
Dr. Cristiana Sieiro Santos delivers a vital expert analysis on the heterogeneous clinical manifestations and unpredictable disease course of Systemic...
Under the Surface: New Perspectives in Lupus with TLR7/8 Inhibition - Report from EULAR 2026
15 Jun 2026
Contributed by Lukas
Dr. Victoria Werth provides an expert analysis of the EULAR 2026 session exploring the role of Toll-like receptor 7 and 8 (TLR7/8) inhibition in syste...
Transitioning Young Patients with Autoinflammatory Diseases to Adult Care: Implications for Daily Clinical Management - Report from EULAR 2026
15 Jun 2026
Contributed by Lukas
Dr. Marco Gattorno provides an essential overview of the EULAR 2026 session focused on the transition of young patients with autoinflammatory diseases...
Advanced Management in Rheumatoid Arthritis: Critical Updates from EULAR 2026
15 Jun 2026
Contributed by Lukas
Professor Ruxandra Ionescu delivers an expert overview of the EULAR 2026 session dedicated to the advanced management of Rheumatoid Arthritis. This co...
Tired Is Not Just a State of Mind: Addressing Pathological Fatigue at EULAR 2026
15 Jun 2026
Contributed by Lukas
Dr. Elena Elefante provides an expert look into the EULAR 2026 joint session "Tired is not just a state of mind," focusing on the clinical r...
Assessment of Disease Activity in Psoriatic Arthritis - Report from EULAR 2026
15 Jun 2026
Contributed by Lukas
Dr. Michael Zauner provides a comprehensive expert overview of the latest advancements in assessing disease activity in Psoriatic Arthritis, presented...
The Benefits of Glucagon/GLP-1 Receptor Dual Agonism: Insights from the SYNCHRONIZE™ Phase 3 Studies of Survodutide
14 Jun 2026
Contributed by Lukas
Dr. Carel le Roux delivers an expert overview of the highly anticipated findings from the SYNCHRONIZE™ Phase 3 clinical studies, presented at the AD...
Lymphoma Highlights and Key Takeaways from the 2026 ASCO Annual Meeting
10 Jun 2026
Contributed by Lukas
Dr. Joshua Brody provides an expert overview of the most impactful clinical updates and essential takeaways from the 2026 ASCO Annual Meeting, focusin...
Immunotherapy in Early-Stage Breast Cancer - Report from ESMO BC 2026
02 Jun 2026
Contributed by Lukas
Professor Giampaolo Bianchini discusses the evolving landscape of immunotherapy in early-stage breast cancer, focusing on predictive biomarkers, patie...
The CAPItello-291 Trial: Final Overall Survival Results of Capivasertib and Fulvestrant in HR+/HER2− Advanced Breast Cancer - Report from ESMO BC 2026
02 Jun 2026
Contributed by Lukas
Professor Hope S. Rugo discusses the final overall survival results from the Phase 3 CAPItello-291 trial, evaluating the efficacy, long-term disease c...
Highlights and key takeaways from the 2026 EPA Congress
15 May 2026
Contributed by Lukas
Professor Meryam Schouler-Ocak provides an expert overview of the most impactful discussions, clinical updates, and essential takeaways from the 2026 ...
Efficacy and Safety of Sotatercept in PH-HFpEF: Results From the Phase 2 CADENCE Trial - report from ACC 2026
22 Apr 2026
Contributed by Lukas
Professor Mardi Gomberg-Maitland presents the results from the Phase 2 CADENCE trial, investigating the efficacy and safety of Sotatercept in patients...
Therapeutic Novelties in the New ACC 2026 Acute Pulmonary Embolism Guideline
22 Apr 2026
Contributed by Lukas
Professor Geoffrey D. Barnes examines the therapeutic innovations introduced in the new ACC 2026 Acute Pulmonary Embolism Guideline, focusing on updat...
Human Challenge Models: A New Gold Standard? - Report from WVCDC 2026
20 Apr 2026
Contributed by Lukas
Dr. Stephen Thomas examines the evolving role of human challenge models in vaccine development, debating whether they represent a new gold standard fo...
The INSIS Metacohort Vaccine Safety Study: A Paradigm for Clinical and Immune AEFI Profiling - Report from WVCDC 2026
20 Apr 2026
Contributed by Lukas
Professor Asimenia Angelidou discusses the INSIS Metacohort Vaccine Safety Study, establishing a new paradigm for profiling clinical and immune advers...
Building a Future of Vaccine Trust Through Transparency and Innovation - Report from WVCDC 2026
17 Apr 2026
Contributed by Lukas
Dr. Yurong Fei-Bloom explores the essential strategies for fostering public confidence in immunization by prioritizing transparency and leveraging tec...
Prove it's safe: Is this the new vaccine policy "norm?" - Report from WVCDC 2026
17 Apr 2026
Contributed by Lukas
Dr. Richard Hughes IV examines the shifting landscape of immunization mandates and public health legislation, questioning whether the heightened deman...
Combining Respiratory Vaccines - Balancing Efficacy, Durability and Immunization Schedules - Report from WVCDC 2026
17 Apr 2026
Contributed by Lukas
Dr. Bill Hausdorff explores the complex dynamics of combining respiratory vaccines, focusing on how to optimize clinical efficacy and long-term durabi...
Discontinuation of β-blocker Therapy in Stabilized Patients After Acute Myocardial Infarction - report from ACC 2026
16 Apr 2026
Contributed by Lukas
Professor Joo-Yong Hahn presents critical insights on the discontinuation of beta-blocker therapy in stabilized patients following an acute myocardial...
Meet the Experts: 2025 High Blood Pressure Guideline - report from ACC 2026
16 Apr 2026
Contributed by Lukas
Professor Daniel Jones joins a panel of distinguished specialists to provide expert commentary on the 2025 High Blood Pressure Guideline, focusing on ...
2026 Acute Pulmonary Embolism Guideline
16 Apr 2026
Contributed by Lukas
Professor Gregory Piazza provides an expert overview of the newly released 2026 Acute Pulmonary Embolism Guideline, focusing on critical updates in di...
Meet the Experts: 2025 High Blood Pressure Guideline - report from ACC 2026
16 Apr 2026
Contributed by Lukas
Professor Keith C. Ferdinand joins a panel of experts to discuss the practical implementation and clinical implications of the 2025 High Blood Pressur...
Kardinal: A Phase 2 Study of Tonlamarsen For the Treatment of Uncontrolled Hypertension - report from ACC 2026
16 Apr 2026
Contributed by Lukas
Dr. Luke Laffin presents the results of the Kardinal Phase 2 study, investigating the efficacy of Tonlamarsen as a novel treatment option for patients...
Pulmonary Embolism in 2026: A Case-Based Journey From Diagnosis to Recovery - report from ACC 2026
16 Apr 2026
Contributed by Lukas
Prof. Stanislav Henkin and Prof. Daniella Kadian-Dodov lead a comprehensive, case-based exploration of pulmonary embolism management in 2026, tracking...
Mavacamten in Symptomatic Adolescent Patients With Obstructive HCM: Results From the Phase 3 Scout-HCM Trial - report from ACC 2026
16 Apr 2026
Contributed by Lukas
Professor Joseph William Rossano presents the highly anticipated results from the Phase 3 Scout-HCM trial, evaluating the efficacy and safety of Mavac...
Saving Women's Hearts - report from ACC 2026
15 Apr 2026
Contributed by Lukas
Professor Roxana Mehran addresses the critical need for gender-specific approaches in cardiovascular care, discussing strategies and clinical advancem...
Highlights of the 2026 ACC/AHA Dyslipidemia Guideline
15 Apr 2026
Contributed by Lukas
Professor Carol F. Kirkpatrick highlights the most critical updates and clinical recommendations from the 2026 ACC/AHA Dyslipidemia Guideline, focusin...
An Update on Cardiac Prevention Medications: Hypertension and Incretin in Focus - report from ACC 2026
15 Apr 2026
Contributed by Lukas
Professor Peter P. Toth provides a comprehensive update on the latest pharmacological strategies in cardiac prevention, specifically focusing on the e...
Effects of Tirzepatide vs. Dulaglutide on Cardiorenal Outcomes: SURPASS-CVOT Analysis - report from ACC 2026
15 Apr 2026
Contributed by Lukas
Professor Steven E. Nissen presents a critical analysis of the SURPASS-CVOT data, comparing the effects of Tirzepatide and Dulaglutide on expanded car...
Next-Generation Lipid Treatment Options - report from ACC 2026
15 Apr 2026
Contributed by Lukas
Professor Robert S. Rosenson explores the evolving landscape of lipid management, detailing next-generation treatment options and their potential to t...
Fine tuning prostate cancer diagnostics - report from EAU 2026
15 Apr 2026
Contributed by Lukas
Professor Armando Stabile discusses the latest advancements and precision methods in fine tuning prostate cancer diagnostics at the EAU 2026 Annual Co...
Prehospital Heparin Administration in Patients With STEMI Undergoing Primary PCI - report from ACC 2026
10 Apr 2026
Contributed by Lukas
Prof. Misa Fister and Prof. Tomaz Goslar evaluate the clinical impact and safety of prehospital heparin administration for patients with STEMI undergo...
Interventional Cardiology Highlights of ACC.26
10 Apr 2026
Contributed by Lukas
Professor Roxana Mehran provides an expert review of the most impactful interventional cardiology developments from the ACC 2026 Annual Congress, focu...
Efficacy and Safety of Enlicitide Decanoate: Results from the Phase 3 CORALreef AddOn Trial - report from ACC 2026
10 Apr 2026
Contributed by Lukas
Professor Alberico L. Catapano presents findings from the Phase 3 CORALreef AddOn trial, evaluating the oral PCSK9 inhibitor enlicitide decanoate vers...
Highlights of ACC.26
10 Apr 2026
Contributed by Lukas
Professor Christopher Kramer shares the most significant breakthroughs, late-breaking clinical trials, and key takeaways from the ACC 2026 Annual Cong...
2026 Acute Pulmonary Embolism Guideline
10 Apr 2026
Contributed by Lukas
Professor Mark A. Creager provides an in-depth overview of the newly released 2026 Acute Pulmonary Embolism Guideline, highlighting key updates in cli...
Cutting-edge strategies in bladder cancer: Trials, techniques, and predictive tools - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Richard P. Meijer explores the frontier of bladder cancer management, focusing on innovative clinical trials, advanced surgical techniques, ...
MIBC - There is a gender bias in bladder cancer diagnosis and treatment - Women experience delays, misdiagnosis, worse outcomes - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Niyati Lobo addresses the critical issue of gender bias in bladder cancer, highlighting how diagnostic delays and misdiagnoses lead to signi...
Guidelines Controversies - Paeds and MIBC - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Antoine G. van der Heijden explores the most debated topics within the EAU Guidelines, focusing on the latest controversies in pediatric uro...
Adaptive recurrence risk predictions to optimise prostate cancer follow-up: Results of model validation and clinical impact - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Joran Schoorlemmer presents the results of model validation and the clinical impact of adaptive recurrence risk predictions, focusing on how these too...
The role of urine biomarkers in detection of bladder cancer - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Yair Lotan examines the clinical utility and future potential of urine biomarkers, focusing on how they are transforming the early detection...
Urology trials in bladder and prostate cancer - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Ashkan Mortezavi provides a comprehensive overview of the most significant recent and ongoing clinical trials in bladder and prostate cancer...
Cutting-edge strategies in bladder cancer: Trials, techniques, and predictive tools - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Nikhil Vasdev explores the latest advancements in bladder cancer management, focusing on clinical trials, innovative surgical techniques, an...
Redefining EMBARK-like Patients in the PSMA Era: Impact of PSMA-PET Restaging on Disease Classification and Management - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Alessandro Viti discusses the impact of PSMA-PET restaging on disease classification and management, redefining "EMBARK-like" pati...
Progression-free survival following primary staging with [¹⁸F]PSMA-1007 PET/ceCT versus Na[¹⁸F]F-PET/ceCT in prostate cancer: Results from the PRISMA PET randomized controlled trial
07 Apr 2026
Contributed by Lukas
Karen Middelbo Buch-Olsen and Mads Hvid Poulsen present the highly anticipated results from the PRISMA PET randomized controlled trial, comparing prog...
2026 EAU Guidelines update and controversies – Urolithiasis, female and male LUTS and infections: What has changed?
07 Apr 2026
Contributed by Lukas
Professor Arjun Konath Nambiar provides a critical update on the 2026 EAU Guidelines, exploring the latest changes and ongoing controversies in urolit...
Infections: Prophylactic antibiotics in renal cancer surgery - Safeguarding patients from postoperative infection - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Florian M. E. Wagenlehner discusses the critical role of prophylactic antibiotics in renal cancer surgery and effective strategies for safeg...
Antibiotics & renal health: Striking the perfect balance between benefit and risk - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Merel M.C. Lambregts discusses the delicate clinical challenge of antibiotics and renal health, exploring how to strike the perfect balance ...
Navigating the future of urologic care - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Andreas Røder discusses the evolving landscape and strategic shifts navigating the future of urologic care at the EAU 2026 Annual Congress....
From MRI to Post-treatment care: prostate cancer screening - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Hendrik Van Poppel discusses the complete pathway of prostate cancer screening, from the initial role of MRI to the nuances of post-treatmen...
Prostate cancer: PARPIs finally explained - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Alexander W. Wyatt breaks down the complexities of PARP inhibitors (PARPIs), providing a clear and comprehensive explanation of their role i...
Retroperitoneal lymph dissection considerations in testicular cancer - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Anna Thor discusses the critical clinical considerations and surgical nuances of retroperitoneal lymph node dissection in the management of ...
How imaging is shaping prostate cancer management: Screening and early detection - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Laurence H. Klotz discusses the promising trends in screening and early detection, highlighting how imaging is shaping the future of prostat...
Advancing BPO treatment: From aquablation to enucleation - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Bogdan Florin Geavlete explores the evolution of BPO treatment, covering advancements from aquablation to enucleation techniques at the EAU ...
Kidney stones made simple: Best clinical practice and preventing complications - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Begoña Ballesta Martínez provides a comprehensive update for all urologists, focusing on best clinical practices and strategies for preven...
Kidney stones made simple: A comprehensive update for all urologists - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Mariela Corrales Acosta provides a comprehensive update on kidney stone management, simplifying complex clinical challenges for all urologis...
Navigating the future of urologic care: Trials in progress - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Tyler M. Seibert discusses the upcoming breakthroughs and ongoing clinical trials navigating the future of urologic care at the EAU 2026 Ann...
How imaging is shaping prostate cancer management - report from EAU 2026
07 Apr 2026
Contributed by Lukas
Professor Giovanni Lughezzani discusses the transformative role of imaging in shaping the management of prostate cancer at the EAU 2026 Annual Congres...
Increasing role of triple therapy in COPD - report from IWLH 2026
30 Jan 2026
Contributed by Lukas
Professor Fabiano Di Marco ediscusses the increasing role of triple therapy in COPD at the 13th International Workshop On Lung Health.Video: https://m...
Redefining epithelial driven airway inflammation: insights from clinical experience with Tezepelumab - report from IWLH 2026
30 Jan 2026
Contributed by Lukas
Professor Corrado Pelaia explains his insights from clinical experience with Tezepelumab at the 13th International Workshop On Lung Health.Video: http...
How should COPD disease characteristics guide therapeutic decisions?
30 Jan 2026
Contributed by Lukas
Professor Dejan Radovanovic discusses how should COPD disease characteristics guide therapeutic decisions at the 13th International Workshop On Lung H...
How to improve the management of newly diagnosed asthma? - report from IWLH 2026
30 Jan 2026
Contributed by Lukas
Professor Guy Brusselle discusses how to improve the management of newly diagnosed asthma at the 13th International Workshop On Lung Health.Video: htt...
Adult Cystic Fibrosis - report from IWLH 2026
30 Jan 2026
Contributed by Lukas
Professor Francesco Blasi explains his thoughts on the treatment of adult cystic fibrosis at the 13th International Workshop On Lung Health.Video: htt...
Clinical remission of asthma: from biologics to inhaled drugs - report from IWLH 2026
30 Jan 2026
Contributed by Lukas
Professor Giorgio Walter Canonica explains his thoughts on the clinical remission of asthma at the 13th International Workshop On Lung Health.Video: h...
Treatment response trajectories to biologics for severe eosinophilic asthma and achievement of clinical remission - report from IWLH 2026
30 Jan 2026
Contributed by Lukas
Professor Johann Christian Virchow discusses the treatment response trajectories to biologics for severe eosinophilic asthma and achievement of clinic...
New Trajectories in Lung Cancer - report from IWLH 2026
30 Jan 2026
Contributed by Lukas
Professor Andrea Bianco discusses the novelties in treatement of lung cancer at the 13th International Workshop On Lung Health.Video: https://medicald...
Vaccinating respiratory patients: a new landscape - report from IWLH 2026
30 Jan 2026
Contributed by Lukas
Professor Francesco Blasi explains his thoughts on vaccinating respiratory patients at the 13th International Workshop On Lung Health.Video: https://m...
Program Director's Choice from SABCS2025 - Part 3: Adding Tucatinib to First-line Maintenance Therapy Delayed Disease Progression in HER2-positive Metastatic Breast Cancer in HER2CLIMB-05 Trial
21 Jan 2026
Contributed by Lukas
Kate Lathrop, MD discuss one of the high impact, clinically relevant, clinical trial, the HER2CLIMB-05 trail that were presented at the San Antonio Br...
Program Director's Choice from SABCS2025 - Part 2: Sacituzumab Govitecan for Endocrine Therapy-refractory Advanced Breast Cancers
21 Jan 2026
Contributed by Lukas
Kate Lathrop, MD discuss one of the high impact, clinically relevant, clinical trial, the ASCENT-07 trial that were presented at the San Antonio Breas...
Program Director's Choice from SABCS2025 - Part 1 : Giredestrant Improves Disease-free Survival in Patients With Early-stage Breast Cancer in Phase III lidERA Trial
21 Jan 2026
Contributed by Lukas
Kate Lathrop, MD discuss one of the high impact, clinically relevant, clinical trial, the lidERA trial that were presented at the San Antonio Breast C...
Highligths of SABCS 2025
13 Jan 2026
Contributed by Lukas
Prof. Virginia G. Kaklamani discuss some of the high impact, clinically relevant, clinical trials that were presented at the San Antonio Breast Cancer...
Available Research Guiding the Selection of Therapy for Patients with Chronic Lymphocytic Leukemia - report from ASH 2025
09 Jan 2026
Contributed by Lukas
Matthew S. Davids discusses the available research guiding the selection of therapy for patients with chronic lymphocytic leukemia at the American Soc...